Antiviral treatment of SARS: can we draw any conclusions?
2003; National Institutes of Health; Volume: 169; Issue: 11 Linguagem: Inglês
Autores Tópico(s)
Viral Infections and Immunology Research
ResumoNow that a novel coronavirus has been well established as the cause of severe acute respiratory syndrome (SARS),[1][1],[2][2] it is important to evaluate what we have learned about the antiviral therapy of SARS. Is ribavirin effective? What other antiviral agents have been tried? What do we know
Referência(s)